What is the difference between Argireline and Palmitoyl Tripeptide-1?

Argireline: Inhibits SNARE complex formation in facial muscles; reduces acetylcholine release locally; relaxes expression lines without systemic effects Palmitoyl Tripeptide-1: Palmitoylated GHK fragment; stimulates collagen I, III, and IV synthesis via TGF-β pathway; increases fibronectin and hyaluronic acid production

Is Argireline FDA approved?

Argireline is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

Is Palmitoyl Tripeptide-1 FDA approved?

Palmitoyl Tripeptide-1 is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

How is Argireline administered in research settings?

In research settings, Argireline is typically administered via the topical route. PeptideBase does not provide dosing or administration instructions.

How is Palmitoyl Tripeptide-1 administered in research settings?

In research settings, Palmitoyl Tripeptide-1 is typically administered via the topical route. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›Argireline vs Palmitoyl Tripeptide-1

Peptide Comparison

Argireline vs Palmitoyl Tripeptide-1

Both are Skin & Cosmetic peptides.

Argireline

Acetyl Hexapeptide-3

Skin & JointNot EvaluatedResearch Only

Half-life: N/A (topical)

18 providers listed

Full Argireline profile →

Palmitoyl Tripeptide-1

Pal-GHK

Skin & JointNot EvaluatedResearch Only

Half-life: N/A (topical)

4 providers listed

Full Palmitoyl Tripeptide-1 profile →

Bottom line

Argireline carries stronger published evidence (RCT, 3 key studies) than Palmitoyl Tripeptide-1 (Review, 2); both are research compounds.

Quick Verdict

Argireline

Evidence

Clinical

Palmitoyl Tripeptide-1

Evidence

Preclinical

Which One Should You Choose?

Your goal	Better option
Stronger clinical evidence	Argireline
More provider options (18 vs 4)	Argireline

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

Argireline

Palmitoyl Tripeptide-1

Mechanism Family

Skin & Cosmetic

Half-life

N/A (topical)

FDA Status

not evaluated

Admin Routes

topical

Availability

Research Only

Providers

18 listed

4 listed

Avail. Notes

Cosmetic peptide (acetyl hexapeptide-3). Sold as cosmetic ingredient by Lipotec/Sederma. Not regulated as a drug by FDA. No NDA or IND. Cosmetic anti-wrinkle ingredient only.

Cosmetic peptide (Pal-GHK, palmitoyl tripeptide-1). Palmitate conjugate of GHK tripeptide. Not regulated as a drug by FDA. No NDA or IND. Cosmetic anti-aging ingredient only.

Research Evidence

Argireline

ClinicalRCT · 3 key studies · most recent 2026

Palmitoyl Tripeptide-1

PreclinicalReview · 2 key studies · dated evidence base — most recent 2015

Research Citations

Argireline

RCT2013 · American Journal of Clinical Dermatology

The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-…

Cohort2026 · Biomater Adv

DES-mediated self-assembled polypeptides: Synergistic neuromuscular signaling inhibition for anti-aging.

RCT2017 · Journal of Cosmetic Dermatology

The efficacy study of the combination of tripeptide-10-citrulline and acetyl hexapeptide-3: a prospective, ra…

Palmitoyl Tripeptide-1

Review2015 · BioMed Research International

GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration

In vitro2012 · Journal of Peptide Science

Stem cell recovering effect of copper-free GHK in skin

About Argireline

Inhibits SNARE complex formation in facial muscles; reduces acetylcholine release locally; relaxes expression lines without systemic effects

Research Areas

SNARE complex (SNAP-25) competitive inhibition reducing expression line depthwrinkle reduction documented in controlled human trialstopical cosmetic application — not a systemic peptidesoftening of dynamic lines over 4–8 weeks at 5–10% concentration

About Palmitoyl Tripeptide-1

Palmitoylated GHK fragment; stimulates collagen I, III, and IV synthesis via TGF-β pathway; increases fibronectin and hyaluronic acid production

Research Areas

collagen synthesisskin firmnessanti-agingwound healing

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Argireline

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Palmitoyl Tripeptide-1

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Find Providers

Where to source these peptides

Providers offering

Argireline

18 listed

Browse directory →

Providers offering

Palmitoyl Tripeptide-1

4 listed

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Skin & Cosmetic Comparisons

Browse all peptides →

Educational research tools — not medical advice.